AIG
SVA

American International Group’s Sinovac Biotech, Ltd SVA Stock Holding History

American International Group’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,900
Closed -$25K – 5215
2016
Q1 		$25K Hold
3,900
– – ﹤0.01% 4227
2015
Q4 		$22K Sell
3,900
-800
-17% -$4.31K ﹤0.01% 4266
2015
Q3 		$24K Hold
4,700
– – ﹤0.01% 4232
2015
Q2 		$24.7K Buy
4,700
+100
+2% +$528 ﹤0.01% 4312
2015
Q1 		$22.8K Hold
4,600
– – ﹤0.01% 4299
2014
Q4 		$24.1K Sell
4,600
-500
-10% -$2.55K ﹤0.01% 4260
2014
Q3 		$24.5K Sell
5,100
-1,400
-22% -$7.52K ﹤0.01% 4256
2014
Q2 		$36.7K Buy
6,500
+1,000
+18% +$6.07K ﹤0.01% 4073
2014
Q1 		$39.6K Buy
5,500
+1,700
+45% +$11.3K ﹤0.01% 3919
2013
Q4 		$23.3K Buy
3,800
+200
+6% +$1.21K ﹤0.01% 4084
2013
Q3 		$21.5K Hold
3,600
– – ﹤0.01% 4046
2013
Q2 		$14.1K Buy
+3,600
New +$13.4K ﹤0.01% 4033

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American International Group's SVA Position: Q2 2016 in Review

American International Group sold out of Sinovac Biotech, Ltd (SVA) in Q2 2016, closing a stake of 3,900 shares — an estimated $25K sold.

American International Group first reported a position in SVA in Q2 2013 and held it in 12 quarters. The position peaked at $39.6K in Q1 2014. 37 funds tracked by Wall St. Rank hold SVA as of Q2 2016.

  • American International Group reported no remaining Sinovac Biotech, Ltd position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 3,900 Sinovac Biotech, Ltd shares in Q2 2016, an estimated $25K.
  • American International Group first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 12 quarters.
  • American International Group's Sinovac Biotech, Ltd position peaked at $39.6K in Q1 2014.
  • 37 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.